DaBomb Protein Corp. produces and supplies plant peptides in Asia. More Details
Mediocre balance sheet and overvalued.
Share Price & News
How has DaBomb Protein's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 6578 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: 6578's weekly volatility (4%) has been stable over the past year.
7 Day Return
TW Personal Products
1 Year Return
TW Personal Products
Return vs Industry: 6578 exceeded the TW Personal Products industry which returned -8% over the past year.
Return vs Market: 6578 underperformed the TW Market which returned 48.1% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is DaBomb Protein's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StDaBomb Protein Corp.'s (GTSM:6578) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
4 months ago | Simply Wall StShould You Be Impressed By DaBomb Protein's (GTSM:6578) Returns on Capital?
5 months ago | Simply Wall StDaBomb Protein (GTSM:6578) Has A Somewhat Strained Balance Sheet
Is DaBomb Protein undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: 6578 (NT$20.35) is trading above our estimate of fair value (NT$3.6)
Significantly Below Fair Value: 6578 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 6578 is unprofitable, so we can't compare its PE Ratio to the TW Personal Products industry average.
PE vs Market: 6578 is unprofitable, so we can't compare its PE Ratio to the TW market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 6578's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 6578 is good value based on its PB Ratio (0.9x) compared to the TW Personal Products industry average (2.2x).
How is DaBomb Protein forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as DaBomb Protein has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has DaBomb Protein performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 6578 is currently unprofitable.
Growing Profit Margin: 6578 is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: 6578 is unprofitable, and losses have increased over the past 5 years at a rate of 44% per year.
Accelerating Growth: Unable to compare 6578's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6578 is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (4.7%).
Return on Equity
High ROE: 6578 has a negative Return on Equity (-2.1%), as it is currently unprofitable.
How is DaBomb Protein's financial position?
Financial Position Analysis
Short Term Liabilities: 6578's short term assets (NT$286.8M) exceed its short term liabilities (NT$126.1M).
Long Term Liabilities: 6578's short term assets (NT$286.8M) exceed its long term liabilities (NT$86.3M).
Debt to Equity History and Analysis
Debt Level: 6578's debt to equity ratio (24.4%) is considered satisfactory.
Reducing Debt: 6578's debt to equity ratio has increased from 9.3% to 24.4% over the past 5 years.
Debt Coverage: 6578's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 6578's interest payments on its debt are well covered by EBIT.
What is DaBomb Protein current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 6578's dividend (0.98%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.98%).
High Dividend: 6578's dividend (0.98%) is low compared to the top 25% of dividend payers in the TW market (5.01%).
Stability and Growth of Payments
Stable Dividend: 6578 is not paying a notable dividend for the TW market, therefore no need to check if payments are stable.
Growing Dividend: 6578 is not paying a notable dividend for the TW market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: 6578 is not paying a notable dividend for the TW market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 6578's dividend in 3 years as they are not forecast to pay a notable one for the TW market.
How experienced are the management team and are they aligned to shareholders interests?
Yu Fen Liu
Ms. Yu Fen Liu serves as Chairman and General Manager of DaBomb Protein Corp. Ms. Liu served as the Chairman of Board of Directors in DaBomb Protein Company Limited. Ms. Liu holds EMBA Degree from National...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.6%.
DaBomb Protein Corp.'s company bio, employee growth, exchange listings and data sources
- Name: DaBomb Protein Corp.
- Ticker: 6578
- Exchange: TPEX
- Founded: 2001
- Industry: Personal Products
- Sector: Household
- Market Cap: NT$612.930m
- Shares outstanding: 30.12m
- Website: https://www.dabombprotein.com
Number of Employees
- DaBomb Protein Corp.
- No.52, Gongye 3rd Road
- Annan District
- Tainan City
DaBomb Protein Corp. produces and supplies plant peptides in Asia. It offers hydrolyzed soya peptide products, functional peptides, and natural lactobacillus strains under the da bomb brand. The company wa...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/21 23:35|
|End of Day Share Price||2021/06/21 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.